The experts said that in the early stage of hypertensive nephropathy、light high blood pressure and the patients with normal urine routine could give non-medicine treatment, keep good emotion、losing weight、limited salt、control liquor、doing qigong and taichi, taking proper exercise and so on. Following content is about the treatment measures for hypertensive nephropathy patients.
1、Patients with malignant renal arteriolar sclerosis in short time, the renal function deteriorates rapidly, with hypertensive encephalopathy、loss of vision quickly、intracranial hemorrhage, and can’t take oral medicine, could be intravenous investigation, usually use sodium nitroprusside, try best in 12-24h control blood pressure. Minoxidil could reduce blood pressure rapidly, is suitable for initial treatment for malignant hypertension.
2、In early stage、light high blood pressure and patients with normal urine routine could offer non-medicine treatment, keep good emotion、loss of weight、limited salt and liquor、doing qigong and taichi, proper exercise and so on.
3、Patients with hyperlipidemia、diabetes and hyperuricemia should provide corresponding kidney treatment. At the same time supply the medicine of anti-platelet and adhesion, such as dipyridamole、aspirin and so on, these medicine maybe have the effect of preventing arteriolar nephrosclerosis.
4、The antihypertensive drugs could be chosen: (1) angiotensin converse enzyme inhibitor; (2) beta blockers; (3) calcium antagonist; (4) diuretic. Calcium antagonist and ACEI are better for haemodynamics of kidney, decreasing urine protein, ACEI is better than other anti-hypertension medication. Controlled blood pressure to normal or near to normal could protect、be stable or delay hypertensive renal damage.
5、Keep bowels open, should take Qing ning pill、Qing ning pill of Mo. Traditional Chinese medicine should choose radix bupleuri definite orange soup、decoction of gastrodia and uncaria and etc.
6、Patients with renal insufficiency should provide non-dialysis treatment and replacement treatment.

没有评论:
发表评论